Joshua Gauci
Associate Director
专长:
Josh has medical writing experience in chronic myeloid leukemia, psoriatic arthritis, B-cell lymphomas, systemic light chain (AL) amyloidosis, and chronic kidney disease. He specializes in developing global value dossiers, clinical summaries, and other value communication materials. Josh holds an MSc in Human Health and Nutritional Sciences from the University of Guelph and is a member of the American Medical Writers Association (AMWA).
Articles by Joshua Gauci
The New AMCP Dossier Format Version 5.0: Key Implications for Strategic Approach
The Academy of Managed Care Pharmacy (AMCP) Format for Formulary Submissions is the industry standard for communicating clinical and economic information to meet the evidentiary requirements/needs of healthcare decision-makers (HCDMs) in the United States. The latest updates to the AMCP Format (version 5.0, published March 31, 2024) have added guidance on health disparities, real-world evidence […]
Considering Commercial Success During Clinical Development: Maintaining a Global Perspective
Although commercial success is the ultimate goal of pharmaceutical research and development (R&D), many new treatments do not meet expectations and fail to achieve broad global reimbursement after initial regulatory approval., This causes therapies to underperform across international markets and, more importantly, limits access for patients in need. For example, only 56% of all new drugs approved by the European Medicines Agency (EMA) […]